GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » LHC Group Inc (NAS:LHCG) » Definitions » Median PS Value

LHC Group (LHC Group) Median PS Value : $92.14 (As of Apr. 25, 2024)


View and export this data going back to 2005. Start your Free Trial

What is LHC Group Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. LHC Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2022 was $74.413. LHC Group's 10-Year median PS Ratio is 1.2382. Therefore, the Median PS Value for today is $92.14.

As of today (2024-04-25), LHC Group's share price is $169.81. LHC Group's Median PS Value is $92.14. Therefore, LHC Group's Price to Median PS Value for today is 1.84.

The historical rank and industry rank for LHC Group's Median PS Value or its related term are showing as below:

LHCG' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.77   Med: 1.75   Max: 3.73
Current: 1.84

During the past 13 years, the highest Price to Median PS Value of LHC Group was 3.73. The lowest was 0.77. And the median was 1.75.

LHCG's Price-to-Median-PS-Value is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 0.74 vs LHCG: 1.84

LHC Group Median PS Value Historical Data

The historical data trend for LHC Group's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LHC Group Median PS Value Chart

LHC Group Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 53.74 55.00 57.13 73.54 92.14

LHC Group Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 73.54 78.20 85.42 90.23 92.14

Competitive Comparison of LHC Group's Median PS Value

For the Medical Care Facilities subindustry, LHC Group's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LHC Group's Price-to-Median-PS-Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, LHC Group's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where LHC Group's Price-to-Median-PS-Value falls into.



LHC Group Median PS Value Calculation

LHC Group's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=74.413*1.2382
=92.14

10-Year Median PS Ratio is 1.2382.
LHC Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $74.413.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LHC Group  (NAS:LHCG) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

LHC Group's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=169.81/92.14
=1.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LHC Group Median PS Value Related Terms

Thank you for viewing the detailed overview of LHC Group's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


LHC Group (LHC Group) Business Description

Traded in Other Exchanges
N/A
Address
901 Hugh Wallis Road South, Lafayette, LA, USA, 70508
LHC Group Inc provides post-acute health care services to patients through its home nursing agencies, community-based services agencies, hospice agencies, and long-term acute care hospitals. The company's home health service locations offer a wide range of services, including skilled nursing, medically-oriented social services and physical, occupational, and speech therapy. Its hospices provide end-of-life care to patients with terminal illnesses through interdisciplinary teams of physicians, nurses, home health aides, counselors, and volunteers. Its other service segments are Home and community based, Facility-based, Hospice and Healthcare Innovations. The company derives most of its revenues from the Home health services.
Executives
Nicholas Iii Gachassin officer: EVP, General Counsel 901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA 70508
Dale Mackel other: CFO 901 HUGH WALLIS ROAD S, LAFAYETTE LA 70508-2511
Reed W Earl Iii director 9510 OMSBY SLATION ROAD, STE 300, LOIISVILLE KY 40223
Kimberly S Seymour other: SVP, Chief Accounting Officer 901 HUGH WALLIS ROAD S, LAFAYETTE LA 70508
Tricia Nguyen other: EVP, Chief Medical Officer 1801 KIRA COURT, ARLINGTON TX 76006
Mcquiddy Collin other: SVP, Chief Accounting Officer 901 HUGH WALLIS ROAD S, LAFAYETTE LA 70508
Donald Dwayne Stelly officer: Senior Vice President 420 WEST PINHOOK ROAD, SUITE A, LAFAYETTE LA 70503
John L Indest director, officer: COO of Home, Senior V.P. 420 WEST PINHOOK ROAD, SUITE A, LAFAYETTE LA 70503
Ronald T Nixon director 1375 ENCLAVE PKWY, HOUSTON TX 77077
Keith G Myers director, 10 percent owner, officer: CEO and President 901 HUGH WALLIS RD S, LAFAYETTE LA 70508
Joshua L. Proffitt officer: Executive Vice President 901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA 70508
Teri G. Fontenot director 18933 EAST PINNACLE CIRCLE, BATON ROUGE LA 70634
Tyree G Wilburn director
Jeff Reibel officer: See Remarks 9510 ORMSBY STATION ROAD, SUITE 300, LOUISVILLE KY 40223
Bruce D Greenstein officer: Chief Innovation Officer 901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA 70508